Search

Your search keyword '"Baldari S"' showing total 494 results

Search Constraints

Start Over You searched for: Author "Baldari S" Remove constraint Author: "Baldari S"
494 results on '"Baldari S"'

Search Results

3. Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)

7. A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer

9. PET Imaging in Gliomas

11. 1394P Alkaline phosphatase (ALP) decline and pain response as markers for overall survival (OS) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (223Ra) in the REASSURE study

12. State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation

13. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

14. Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study

18. Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors

20. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

29. Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas

32. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study

34. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

35. Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study

38. Regenerative medicine approaches for the management of respiratory tract fistulas

41. Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)

42. Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT

49. Tumour Growth Rate (TGR) to Monitor Growth/Predict Response to Lanreotide Autogel (LAN) Use before, during and after Peptide Receptor Radionuclide Therapy (PRRT) in Advanced Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs): Data from PRELUDE

Catalog

Books, media, physical & digital resources